Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03790436 · ClinicalTrials.gov registry record · NA
Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet
A NA study, sponsored by University of Southern California.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT03790436 is a NA study that was terminated before completion, run by University of Southern California. The registered enrollment target is 10 participants.
The verdict
NCT03790436, a NA study, was terminated before completion, sponsored by University of Southern California.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this pilot study is to measure adherence and quality of life in adults with intractable epilepsy following the Modified Atkins Diet (MAD) with Betaquik, a ready-to-use medium chain triglyceride (MCT) emulsion, as an adjunct to the MAD.
Interventions
- DIETARY_SUPPLEMENT Betaquik
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-09-14 |
| Est. Completion | 2021-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03790436
The ClinicalTrials.gov registry entry for NCT03790436 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Southern California, which has 617 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Betaquik is the first listed.
NCT03790436 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03790436 about?
NCT03790436 is a clinical study titled "Betaquik as an Adjunct to Dietary Management of Epilepsy in Adults on the Modified Atkins Diet". The purpose of this pilot study is to measure adherence and quality of life in adults with intractable epilepsy following the Modified Atkins Diet (MAD) with Betaquik, a ready-to-use medium chain triglyceride (MCT) emulsion, as an adjunct to the MAD.
What is the current status of trial NCT03790436?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2018-09-14. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03790436?
The interventions under investigation include: Betaquik (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03790436?
This trial is sponsored by University of Southern California, which has 617 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.